# ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
> **ANDA202912** · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2013-12-05
## Drug
- **FDA Application Number:** ANDA202912
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
- **Generic name:** ABACAVIR , LAMIVUDINE AND ZIDOVUDINE
- **Active ingredients:** ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LUPIN
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2013-12-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202912)
---
*AI Analytics · CC0 1.0*